LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Opinions
  • |My Feed
  • |Events
  • |Company Directory
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Foot & Ankle/Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus
Foot & Ankle

Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus

By Carl StearnsNovember 17, 2026 2 min read Premium comments

Advertisement

Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus
Photo courtesy of Hyalex Orthopaedics

LEXINGTON, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Hyalex® Orthopaedics today announced the successful completion of the first procedure utilizing the HYALEX Slalom™ MTP Hemiarthroplasty Implant, performed by foot and ankle surgeon Jesse Doty, M.D., of Integrity Orthopedics and Sports Medicine in Chattanooga, TN. This milestone marks an important advancement in the treatment of Hallux Rigidus, offering a motion-preserving alternative for patients suffering from painful arthritis of the first metatarsophalangeal (MTP) joint.

Hallux Rigidus is the most common arthritic condition affecting the great toe joint and can result in pain, stiffness, decreased range of motion, and limitations in daily activities. While first MTP joint fusion has long been considered a reliable surgical option for advanced disease, patients and surgeons continue to seek alternatives that address pain while preserving joint motion.

"One of the ongoing challenges in treating Hallux Rigidus is helping patients maintain function and mobility while addressing pain in the first MTP joint," said Dr. Doty. "The HYALEX Slalom MTP implant provides a surgical option for appropriately selected patients who desire motion and joint preservation. I'm excited to complete the first case and look forward to evaluating patient outcomes as we continue to expand the treatment options available for Hallux Rigidus."

"The first HYALEX Slalom MTP procedure represents an important milestone for Hyalex Orthopaedics and for surgeons treating first MTP arthritis," said Carl Vause, Chief Executive Officer of Hyalex Orthopaedics. "Leveraging our propriety Hydrosurf™ material, this implant is intended to expand the treatment options available to surgeons and patients seeking to maintain motion in the first MTP joint. "We are proud to partner with innovative surgeons like Dr. Doty as we advance new treatment options for patients utilizing our transformative materials technology and joint preserving implant design."

About Hyalex Orthopaedics

Hyalex is a privately held medical device company headquartered in Lexington, MA, developing transformational joint preservation technologies for diseased and damaged joints. The HYALEX Hydrosurf™ materials platform is protected by more than twenty-five patents and trademarks worldwide. The HYALEX Freestyle™ Knee Resurfacing System has received Investigational Device Exemption (IDE) Approval from the United States Food and Drug Administration for a clinical trial in the United States.

For more information: www.hyalex.com

Contact Information:

Deborah Leahy
Hyalex Orthopaedics
deb.leahy@hyalex.com
978-376-0093

Author

CS
Carl Stearns

Why This Matters

Two Perspectives

MBA Lens: Economic and industry impact

Hyalex Orthopaedics completed the first commercial procedure with its HYALEX Slalom™ MTP Hemiarthroplasty Implant, targeting Hallux Rigidus. This motion-preserving device aims to capture market share by offering an alternative to traditional fusion, addressing patient and surgeon demand for joint preservation. The company leverages its proprietary Hydrosurf™ material to expand treatment options and strengthen its position in the foot and ankle market, marking a strategic entry point.

  • The Slalom MTP implant offers a motion-preserving alternative to fusion for Hallux Rigidus, addressing a key market need.
  • This first commercial case signifies Hyalex's strategic entry into the MTP joint arthritis market, utilizing its proprietary Hydrosurf™ material.

PhD Lens: Clinical and outcomes impact

The HYALEX Slalom™ MTP Hemiarthroplasty Implant, utilizing proprietary Hydrosurf™ material, offers a motion-preserving surgical option for Hallux Rigidus. This device aims to alleviate pain and restore function in the first MTP joint, contrasting with joint fusion. The initial commercial procedure marks its introduction, with future evaluation of patient outcomes anticipated to establish its clinical efficacy and long-term safety profile.

  • The implant is designed to preserve motion in the first MTP joint for Hallux Rigidus patients using proprietary Hydrosurf™ material.
  • This announcement details the first commercial procedure; clinical evidence on long-term outcomes and safety is pending.
React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

Orthopedics This Week’s mission is to connect the orthopedic community with the people, ideas, and innovations shaping the future of musculoskeletal care.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Opinions
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, opinions, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy